indications for glp 1 agonist GLP-1 Drugs: Where We Are and Where We're Going — Summit Re GLP-1 Receptor Agonists in Solid

These findings are consistent with recent NORC data showing that people are increasingly using AI for health information but still trust information from AI less than that from medical, personal, and social media sources

Feb 2, 2026 By Maggie Fick, Bhanvi Satija and Mariam Sunny LONDON, Feb 2 (Reuters) - The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is looking a lot less certain with U.S

Without changes to lifestyle, weight that took months to shed is rapidly regained once the medication is discontinued, reversing the improvements to metabolic health

344:d7771